Literature DB >> 21167353

Dormant pulmonary vein conduction induced by adenosine in patients with atrial fibrillation who underwent catheter ablation.

Seiichiro Matsuo1, Teiichi Yamane, Taro Date, Nicolas Lellouche, Ken-Ichi Tokutake, Mika Hioki, Keiichi Ito, Ryohsuke Narui, Shin-Ichi Tanigawa, Tokiko Nakane, Michifumi Tokuda, Seigo Yamashita, Yasuko Aramaki, Keiichi Inada, Kenri Shibayama, Satoru Miyanaga, Hiroshi Yoshida, Hidekazu Miyazaki, Kunihiko Abe, Ken-Ichi Sugimoto, Ikuo Taniguchi, Michihiro Yoshimura.   

Abstract

BACKGROUND: intravenous administration of adenosine triphosphate (ATP) is used to induce transient pulmonary vein (PV) reconduction (dormant PV conduction) following PV isolation. This study investigated the detailed characteristics of dormant PV conduction in patients with atrial fibrillation (AF) who underwent catheter ablation.
METHODS: two hundred sixty consecutive patients (235 men; mean age, 54 ± 10 years) who underwent catheter ablation of their AF were included in this study. ATP was injected following PV isolation to induce dormant PV conduction, which was then eliminated by radiofrequency application.
RESULTS: dormant PV conduction was induced by ATP in 60.4% (157/260) of the patients and in 25.3% (258/1,021) of the isolated PVs. This transient PV reconduction was more frequently observed in the left superior PV in comparison with other PVs (P < .0001). There was no significant difference in the prevalence of the dormant PV conduction among patients with paroxysmal AF, persistent AF, and long-lasting AF (62%, 66%, and 48%, respectively; P = .13). During the follow-up period, repeat AF ablation was performed in 70 patients with recurrent AF. The dormant PV conduction was less frequently induced in the repeat procedure than in the initial procedure (60.4% vs 31.4%, P < .0001).
CONCLUSIONS: dormant PV conduction was evenly induced among AF types. The repeat PV isolation led to the decrease in incidence of the ATP-induced acute transient pharmacological PV reconduction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21167353     DOI: 10.1016/j.ahj.2010.10.016

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

Review 1.  Comparison of the Efficacy of PVAC® and nMARQ for paroxysmal atrial fibrillation.

Authors:  Avishag Laish-Farkash; Mahmoud Suleiman
Journal:  J Atr Fibrillation       Date:  2017-04-30

2.  Atrial fibrillation diagnosed by a medical checkup is associated with a poor outcome of catheter ablation.

Authors:  Ryohsuke Narui; Teiichi Yamane; Michifumi Tokuda; Hirotsugu Ikewaki; Eri Okajima; Hidenori Sato; Hirotsuna Oseto; Ryota Isogai; Kenichi Tokutake; Kenichi Yokoyama; Mika Kato; Keiichi Ito; Shin-Ichi Tanigawa; Seigo Yamashita; Keiichi Inada; Seiichiro Matsuo; Satoru Miyanaga; Kenichi Sugimoto; Michihiro Yoshimura
Journal:  Heart Vessels       Date:  2018-01-22       Impact factor: 2.037

3.  Adenosine triphosphate-induced atrial fibrillation: the clinical significance and relevance to spontaneous atrial fibrillation.

Authors:  Susumu Tao; Yasuteru Yamauchi; Shingo Maeda; Hiroyuki Okada; Tetsuo Yamaguchi; Nobuhiro Hara; Yuji Konishi; Tomoyuki Umemoto; Takamichi Miyamoto; Tohru Obayashi; Kenzo Hirao; Mitsuaki Isobe
Journal:  J Interv Card Electrophysiol       Date:  2013-12-10       Impact factor: 1.900

Review 4.  How To Achieve Durable Pulmonary Vein Antral Isolation?

Authors:  Y Darrat; G Morales; Biase L Di; A Natale; C S Elayi
Journal:  J Atr Fibrillation       Date:  2014-04-30

Review 5.  Who Needs Catheter Ablation And Which Approach?

Authors:  Duygu Kocyigit; Ugur Canpolat; Kudret Aytemir
Journal:  J Atr Fibrillation       Date:  2015-12-31

6.  Response of circulating heat shock protein 70 and anti-heat shock protein 70 antibodies to catheter ablation of atrial fibrillation.

Authors:  Jelena Kornej; Claudia Reinhardt; Jedrzej Kosiuk; Arash Arya; Gerhard Hindricks; Volker Adams; Daniela Husser; Andreas Bollmann
Journal:  J Transl Med       Date:  2013-02-23       Impact factor: 5.531

Review 7.  Paroxysmal atrial fibrillation ablation: Achieving permanent pulmonary vein isolation by point-by-point radiofrequency lesions.

Authors:  Alonso Pedrote; Juan Acosta; Beatriz Jáuregui-Garrido; Manuel Frutos-López; Eduardo Arana-Rueda
Journal:  World J Cardiol       Date:  2017-03-26

Review 8.  Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis.

Authors:  Anand N Ganesan; Nicholas J Shipp; Anthony G Brooks; Pawel Kuklik; Dennis H Lau; Han S Lim; Thomas Sullivan; Kurt C Roberts-Thomson; Prashanthan Sanders
Journal:  J Am Heart Assoc       Date:  2013-03-18       Impact factor: 5.501

9.  Spatial distribution of electrical reconnection after pulmonary vein isolation in patients with recurrent paroxysmal atrial fibrillation.

Authors:  L M Rademakers; I Romero; T A Simmers; P H van der Voort; A M Meijer; L R Dekker
Journal:  Neth Heart J       Date:  2016-07       Impact factor: 2.380

10.  Efficacy of isoproterenol in the evaluation of dormant conduction and arrhythmogenic foci identification in atrial fibrillation ablation.

Authors:  Yusuke Sakamoto; Hiroyuki Osanai; Shotaro Hiramatsu; Hikari Matsumoto; Kensuke Tagahara; Hirotaka Hosono; Shun Miyamoto; Hiroto Uno; Hideki Kurokawa; Shun Kondo; Kotaro Tokuda; Takahiro Kanbara; Yoshihito Nakashima; Hiroshi Asano; Masayoshi Ajioka
Journal:  BMC Cardiovasc Disord       Date:  2020-08-31       Impact factor: 2.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.